Markers of insulin resistance in perimenopausal women with endometrial pathology
article
OA: gold
CC0
⤵ 2 in-corpus citations
AI-generated summary
Perimenopausal women with endometrial pathology exhibited a higher prevalence of insulin resistance and abnormal carbohydrate metabolism parameters, with 120-minute OGTT insulin levels correlating with hyperplastic lesions.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVES: To determine and compare the prevalence of insulin resistance and carbohydrate metabolism parameters in women with endometrial pathology MATERIAL AND METHODS: 100 perimenopausal women with abnormal uterine bleeding and/or abnormal endometrium were included into the study. Hysteroscopy with biopsy was performed. The study population was divided into four groups according to histopathological results of the endometrium: non-atypical endometrial hyperplasia, endometrial polyp, endometrial cancer and controls. Fasting glucose and insulin levels and OGTT, IR indexes, occurrence of diabetes, pre-diabetic state, overweight, obesity and hypertension were assessed. RESULTS: Insulin resistance was diagnosed in 41.0% of the patients. The prevalence of markers of insulin resistance increased to 57.1% in cases with confirmed endometrial pathology compared to 31.8% in histologically normal endometrium (p<0.01). The frequency of insulin resistance was 52.6% (p=0.059) and 55.5% (p=0.04), respectively in women with non-atypical hyperplasia and patients with endometrial polyps when compared to the control group. Abnormal parameters of carbohydrate metabolism indicate little sensitivity and specificity in predicting endometrial hyperplastic lesions. The insulin levels at 120 minutes of OGTT correlate best with such changes (concentration >57 microU/ml in case of hyperplasia and >61 microU/ml in endometrial polyps). CONCLUSION: Insulin resistance and carbohydrate metabolism disturbances are common in women with endometrial pathologies. In these patients there is clinical basis for recommending lifestyle modification (change of diet, more physical activity), or for introduction of pharmaceutical insulin-sensitizing agents.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- Risk factors for endometrial hyperplasia: Results from a case-control study 2002
- Uterine disease in midlife and beyond: the menopausal transition and postmenopause 2008
Cited by (2)
References (51)
- Risk factors for endometrial hyperplasia: Results from a case-control study via openalex
- Uterine disease in midlife and beyond: the menopausal transition and postmenopause via openalex
- doi:10.1016/j.beem.2006.03.005 via openalex
- doi:10.1016/s0015-0282(03)01183-x via openalex
- doi:10.1016/s0002-9378(98)70244-3 via openalex
- doi:10.1002/ijc.11544 via openalex
- doi:10.4158/ep.17.6.949 via openalex
- doi:10.1016/0960-0760(91)90033-2 via openalex
- doi:10.1067/mob.2003.247 via openalex
- doi:10.1038/bjc.1988.44 via openalex
- doi:10.1002/ijc.2910590303 via openalex
- doi:10.2165/00003495-199958001-00003 via openalex
- doi:10.1016/s0029-7844(00)01059-0 via openalex
- doi:10.2337/diacare.14.12.1132 via openalex
- doi:10.1016/j.curobgyn.2003.12.002 via openalex
- doi:10.1055/s-2004-814147 via openalex
- doi:10.1097/00042192-199906010-00013 via openalex
- doi:10.1159/000080189 via openalex
- doi:10.1016/s0378-5122(01)00247-x via openalex
- doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1053>3.0.co;2-t via openalex
- W1592278156 via openalex
- W1690780888 via openalex
- doi:10.1210/edrv-11-3-443 via openalex
- doi:10.1158/1055-9965.epi-06-0751 via openalex
- doi:10.1097/00006250-200012000-00004 via openalex
- doi:10.1210/jcem-67-1-144 via openalex
- W2108881204 via openalex
- doi:10.1093/oxfordjournals.aje.a009301 via openalex
- doi:10.1038/oby.2002.203 via openalex
- W2409694643 via openalex
- W2417430527 via openalex
- doi:10.1210/jcem.77.1.7686914 via openalex
- doi:10.1097/00006250-200308000-00039 via openalex
- doi:10.3109/9780203091500.055 via openalex
- doi:10.1002/cncr.11334 via openalex
- doi:10.1016/s1074-3804(05)60178-8 via openalex
- doi:10.1016/s0026-0495(97)90159-1 via openalex
- doi:10.3109/9780203091500-59 via openalex
- doi:10.1007/bf00280883 via openalex
- doi:10.1093/jnci/djh291 via openalex
- doi:10.1016/j.ejca.2008.05.001 via openalex
- doi:10.1056/nejmoa021423 via openalex
- doi:10.1136/ijgc-00009577-200205000-00004 via openalex
- doi:10.1016/j.jmig.2008.11.004 via openalex
- doi:10.1038/modpathol.3880051 via openalex
- doi:10.2337/dc07-1443 via openalex
- doi:10.1007/s00432-004-0587-2 via openalex
- doi:10.1002/ijc.1285 via openalex
- doi:10.1007/s004040050241 via openalex
- doi:10.1210/jc.77.1.199 via openalex
- doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-14T06:52:15.578221+00:00
License: CC0
· commercial use OK